Enlivex Therapeutics Ltd. ENLV

$ 1.25 5.81%

Annual report 2023
added 12-21-2024

Enlivex Therapeutics Ltd. Cash and Cash Equivalents 2011-2024 | ENLV

Annual Cash and Cash Equivalents Enlivex Therapeutics Ltd.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	5.67 M	3.95 M	377 K	3.53 M	6.87 M	262 K	10.6 M	270 K	146 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.6 M	146 K	3.52 M

Quarterly Cash and Cash Equivalents Enlivex Therapeutics Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	11.2 M	-	12.6 M	53.2 M	5.67 M	-	10.2 M	24.8 M	3.95 M	-	16.1 M	-	9.74 M	-	-	-	9.03 M	-	-	-	3.04 M	-	-	-	7.29 M	-	-	-	10.6 M	-	-	-	270 K	-	-	-	146 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
53.2 M	146 K	11.9 M